Evidence map›Paper›PMID 34987597›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2021

GC/MS Profiling and

Nahla Ayoub, Nadia Badr, Saeed S Al-Ghamdi, Arwa Alzahrani, Rahaf Alsulaimani, Afnan Nassar, Rawabi Qadi, Ibtesam K Afifi, Noha Swilam

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Nahla AyoubDepartment of Pharmacology and Toxicology, Faculty of Medicine, Umm Al-Qura University (UQU), Makkah, Saudi Arabia.ORCID https://orcid.org/0000-0003-4490-889X
Nadia BadrDepartment of Dental Biomaterials, Faculty of Dentistry, Umm Al-Qura University (UQU), Makkah, Saudi Arabia.
Saeed S Al-GhamdiDepartment of Pharmacology and Toxicology, Faculty of Medicine, Umm Al-Qura University (UQU), Makkah, Saudi Arabia.
Arwa AlzahraniBachelor of Dental Surgery, Faculty of Dentistry, Umm Al-Qura University (UQU), Makkah, Saudi Arabia.
Rahaf AlsulaimaniBachelor of Dental Surgery, Faculty of Dentistry, Umm Al-Qura University (UQU), Makkah, Saudi Arabia.
Afnan NassarDepartment of Preventive Dentistry, Public Health, Faculty of Dentistry, Umm Al-Qura University (UQU), Makkah, Saudi Arabia.ORCID https://orcid.org/0000-0002-2723-3395
Rawabi QadiDepartment of Pharmacology and Toxicology, Faculty of Medicine, Umm Al-Qura University (UQU), Makkah, Saudi Arabia.
Ibtesam K AfifiDepartment of Basic and Clinical Oral Sciences, Faculty of Dentistry, Umm Al-Qura University (UQU), Makkah, Saudi Arabia.
Noha SwilamDepartment of Pharmacognosy, Faculty of Pharmacy, The British University in Egypt (BUE), Cario, Egypt.ORCID https://orcid.org/0000-0003-1846-2265
Umm al-Qura University · SABritish University in Egypt · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introduction

methodsThe gas chromatography mass spectrometry (GC/MS) analysis was carried out to identify the components of SPE. First, the consistency of SPE was accomplished according to ANSI/ADA specification no 57. Forty-five single-rooted mandibular premolars were infected with that of

resultsThirty-two compounds were identified (89.09%), with main components of benzyl isothiocyanate (BITC) (33.32%) and steroids (34%). CFU before and after using SPE and Ca(OH)

conclusionThis finding could be referred to the high content of bactericidal BITC in synergism with other antimicrobial components, representing 70.71% of SPE. Thus, SPE is a good candidate as an intracanal medicament, which warrants further investigation.

Identifiers

PMID34987597
PMCPMC8723863
OpenAlexW4200034331

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.